Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Sanofi compounds with potent and selective affinity for CB2 receptors

Aug. 5, 1997

Pause in SNX-111 head trauma trial enrollment announced

Aug. 5, 1997

Zeneca's Seroquel deemed approvable by FDA

Aug. 4, 1997

Merck & Co. discloses new substance P antagonists

Aug. 4, 1997

NeoTherapeutics reports interim results from clinical trial with AIT-082

Aug. 1, 1997

New application for long-established local anesthetic

Aug. 1, 1997

Esteve describes glutamate release inhibitors

Aug. 1, 1997

University of Minnesota researchers report kappa-receptor ligands

Aug. 1, 1997

Potent calpain inhibitor discovered at Senju

July 31, 1997

Agents for Parkinson's disease prepared at Rhone-Poulenc Rorer

July 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...